A Global Leading Company in Antibody Therapeutics

About Us History

2016
  • 06.

    Y-Biologic Inc. merged ANRT Inc. to Y-Biologics Inc

  • 05.

    Research collaboration agreement with CJ Health Care on three research items

  • 05.

    Research collaboration agreement with LegoChem Bio. on a antibody-ADC development

  • 04.

    Fund raising (about 10m$)

2015
  • 08.

    Participant of Seoul National university,
    Center for Research on hospital

  • 06.

    Collaboration agreement with
    Young-Nam MS Smart ageing Consortium.

2014
  • 08.

    Contract extension with Sanofi for the study of
    anti-hepatoma target antibody

  • 07.

    Collaboration agreement with Gacheon MS for
    development anti-metabolic antibody drug

  • 06.

    Collaboration agreement with Asan MC for
    ADC developement Renamed as ANRT

2013
  • 10.

    Collaboration agreement with Inje Ocular Neovasculation
    center for MD antibody Drug

  • 08.

    Collaboration agreement with Inje MS for the study of
    ICP target

2012
  • 11.

    Contract with Sanofi for the study of anti-hepatoma target
    antibody

2011
  • 07.

    Collaboration agreement with Sanofi for the study of
    anti-cancer antibody drug

2010
  • 03.

    First licensing out to Han-All phama.

2009
  • 09.

    Research Center is registered.

  • 06.

    Korean Government certify as Venture Company.

2007
  • 12.

    ANR Therapeutics Inc. was made.